Tag

Srinivas Sadu

1 article

Gland Pharma Q2 PAT Surges 58% to ₹2.9B

Gland Pharma reported Q2FY27 consolidated revenue of ₹18,336 million, a 23% YoY increase, driven by strong execution across businesses. Profit After Tax (PAT) grew 58% YoY to ₹2,908 million, with PAT